AUSTAR Posts Zero Share Capital Changes in July 2026, Confirms Public Float Compliance

Bulletin Express08-06

Austar Lifesciences Limited (AUSTAR) filed its Monthly Return for Equity Issuer for the period ended 31 July 2026, showing no changes in share capital structure or outstanding equity instruments.

The company’s authorised share capital remained at 10.00 billion ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 100.00 million. Issued share capital was unchanged at 512.58 million ordinary shares, and the company held no treasury shares.

AUSTAR reported no activity in share options, warrants, convertible securities or other equity-linked agreements during the month, indicating no dilution events.

Management confirmed that the public float continues to meet the Main Board’s minimum 25% requirement, ensuring compliance with Hong Kong Stock Exchange listing rules.

The monthly return was submitted on 6 August 2026 and signed by Company Secretary Mak Yuk Kiu.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment